Olivier Baud

Dr. Olivier Baud


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in The Lancet
Verified
Journal Article
Closed access
OBOlivier Baud
Olivier Baud
LMLaure Maury
Laure Maury
FLFlorence Lebail
Florence Lebail
DRDuksha Ramful
Duksha Ramful
FMFatima El Moussawi
Fatima El Moussawi
CACorinne Alberti
Corinne Alberti

4 April 2017 in JAMA
Verified
Journal Article
Open access
PDF file
OBOlivier Baud
Olivier Baud
CTClémence Trousson
Clémence Trousson
VBValérie Biran
Valérie Biran
ELEmilie Leroy
Emilie Leroy
DMDamir Mohamed
Damir Mohamed
FGfor the PREMILOC Trial Group
for the PREMILOC Trial Group
Preterm birth is frequently associated with perinatal inflammation, a major risk factor for bronchopulmonary dysplasia, brain damage, and subsequent neurodevelopmental impairments.1,2 Because glucocorticoids alleviate systemic inflammation, they have been proposed as a therapeutic option in very preterm infants. Quiz Ref ID Postnatal dexamethasone therapy led to short-term benefits, including decreasing the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia, but was associated with cerebral palsy and other adverse neurodevelopmental events.3

1 February 2013 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
SGSonia Guillaume
Sonia Guillaume
NMNatacha Michelin
Natacha Michelin
EAElodie Amrani
Elodie Amrani
BBBrigitte Benier
Brigitte Benier
XDXavier Durrmeyer
Xavier Durrmeyer
LCLaurence Caeymaex
Laurence Caeymaex
Background: During the first weeks of hospitalization, premature babies and their parents encounter difficulties in establishing early bonds and interactions. Only a few studies have explored what caregivers can do to meet parents' needs in relation to these interactions and help optimize them. This study sought to explore parents' perception of these first interactions and to identify the actions of caregivers that help or hinder its development. Methods: Prospective study, qualitative discourse analysis of 60 face-to-face interviews conducted with 30 mothers and 30 fathers of infants born before 32 weeks of gestation (mean ± SD: 27 ± 2 weeks of gestational age), during their child's stay in one out of three NICUs in France. Interviews explored parental experience, from before birth up to the first month of life. Results: Data analysis uncovered two main themes, which were independent of parents' geographical or cultural origin but differed between mothers and fathers. First, fathers described the bond with their child as composed more of words and looks and involving distance, while mothers experienced the bond more physically. Secondly, two aspects of the caregivers' influence were decisive: nurses' caring attitude towards baby and parents, and their communication with parents, which reduced stress and made interactions with the baby possible. This communication appeared to be the locus of a supportive and fulfilling encounter between parents and caregivers that reinforced parents' perception of a developing bond. Conclusions: At birth and during the first weeks in the NICU, the creation of a bond between mothers and fathers and their premature baby is rooted in their relationship with the caregivers. Nurses' caring attitude and regular communication adapted to specific needs are perceived by parents as necessary preconditions for parents' interaction and development of a bond with their baby. These results might allow NICU staff to provide better support to parents and facilitate the emergence of a feeling of parenthood.

22 September 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
POPaul Olivier
Paul Olivier
RFRomain H. Fontaine
Romain H. Fontaine
GLGauthier Loron
Gauthier Loron
JSJuliette Van Steenwinckel
Juliette Van Steenwinckel
VBValérie Biran
Valérie Biran
OBOlivier Baud
Olivier Baud
To investigate the effects of melatonin treatment in a rat model of white matter damage (WMD) in the developing brain. Additionally, we aim to delineate the cellular mechanisms of melatonin effect on the oligodendroglial cell lineage. A unilateral ligation of the uterine artery in pregnant rat at the embryonic day 17 induces fetal hypoxia and subsequent growth restriction (GR) in neonatal pups. GR and control pups received a daily intra-peritoneal injection of melatonin from birth to post-natal day (P) 3. Melatonin administration was associated with a dramatic decrease in microglial activation and astroglial reaction compared to untreated GR pups. At P14, melatonin prevented white matter myelination defects with an increased number of mature oligodendrocytes (APC-immunoreactive) in treated GR pups. Conversely, melatonin was not found to be associated with an increased density of total oligodendrocytes (Olig2-immunoreactive), suggesting that melatonin is able to promote oligodendrocyte maturation but not proliferation. These effects appear to be melatonin-receptor dependent and were reproduced in vitro. These data suggest that melatonin has a strong protective effect on developing damaged white matter through decreased microglial activation and oligodendroglial maturation leading to a normalization of the myelination process. Consequently, melatonin should be a considered as an effective neuroprotective candidate not only in perinatal brain damage but also in inflammatory and demyelinating diseases observed in adults.

30 September 2016 in Glia
Verified
Journal Article
Closed access
PDF file
ANAline Rideau Batista Novais
Aline Rideau Batista Novais
HPHoa Pham
Hoa Pham
VYvan de Looij Yohan
van de Looij Yohan
MBMiguel Bernal
Miguel Bernal
JMJerome Mairesse
Jerome Mairesse
OBOlivier Baud
Olivier Baud

1 January 2013
Verified
Book Chapter
Closed access
OBOlivier Baud
Olivier Baud
YAYannick Aujard
Yannick Aujard